Monthly Archives

September 2025

Sep 30
Love0

SOCU Faculty Research: Thiamidol for Hyperpigmentation

By Skin of Color Update Agenda

hyperpigmentation

Skin of Color Update faculty are experts in skin of color dermatology. Eight faculty members were involved with this recent Journal of Drugs in Dermatology article on Thiamidol as a treatment for hyperpigmentation.

Drs. Cheri Frey, Pearl Grimes, Valerie Callender, Andrew Alexis, Hilary Baldwin, Nada Elbuluk, Susan Taylor, and Seemal Desai conducted the review of pre-clinical and clinical safety and efficacy data of Thiamidol formulations. Thiamidol or isobutylamido thiazolyl resorcinol, has been identified as the most effective human tyrosinase inhibitor out of 50,000 compounds screened. The researchers wrote that Thiamidol appears to be safe and effective and should be considered when recommending over-the-counter treatment options to patients with hyperpigmentation.

For the latest research and updates in the treatment of hyperpigmentation, attend Skin of Color Update. Register today!

Sep 22
Love0

SOCU Faculty Research: Low-dose Spironolactone for Hair Loss in Women

By Sessions

low-dose spironolactone

Skin of Color Update faculty member Maryanne Makredes Senna, MD, FAAD, published research in the Journal of Drugs in Dermatology on the efficacy of low-dose spironolactone for hair loss in women.

Dr. Makredes Senna and her colleagues conducted a retrospective chart review of adult women with female pattern hair loss who were treated with 50 mg or less daily of spironolactone either alone or in combination with other therapies. Results showed a statistically significant decline in the average Sinclair Score in patients treated with spironolactone as monotherapy (2.63 to 1.95) after one year. Including patients on other therapies, such as such as topical minoxidil 5% foam or low-level light laser treatment, results also showed a significant decrease (2.47 to 1.81) after one year.

Attend Dr. Makredes Senna’s hair loss sessions at Skin of Color Update for the latest in treatments for scarring and non-scarring alopecias. Register today!

Sep 18
Love0

SOCU Faculty in the News: Dr. Karan Lal

By Skin of Color Update Agenda

pediatric psoriasis

Skin of Color Update faculty member Karan Lal, DO, FAAD, wrote the August cover story for Dermatology Times on the hidden burdens of pediatric psoriasis.

In the article, Dr. Lal addresses the need for early intervention and awareness of systemic comorbidities linked to pediatric psoriasis, including uveitis, arthritis, obesity, type 2 diabetes (T2D), and metabolic syndrome. Dr. Lal also comments on  available therapies and treatment obstacles in this patient population.

Dr. Lal will participate in an expert discussion at Skin of Color Update on addressing comorbidities in dermatologic disorders, including psoriasis and hidradenitis suppurativa. This discussion will also address the potential role of GLP-1 agonists. In addition, Dr. Lal will present on pediatric dermatology pearls for treating patients with skin of color.

Register for Skin of Color Update and attend lectures by premier experts in dermatology on topics that impact your patients.

Sep 08
Love1

JDD Video Abstract with Dr. Cheri Frey

By Aesthetic Dermatology

pre-aging

Skin of Color Update faculty member Cheri Frey, MD, FAAD, recently shared a video abstract of her Journal of Drugs in Dermatology study evaluating the benefits of acetyl dipeptide-31 amide (AP31) for pre-aging skin.

Watch as Dr. Frey outlines the signs of pre-aging and the goal of prejuvenation. Learn how Dr. Frey and her colleagues conducted their research on AP31 and their results. Find out her takeaways and how dermatologists are now addressing aging skin before changes are visible.

Dr. Frey will lecture on cosmeceuticals and exosomes at Skin of Color Update. Register today!

Sep 03
Love1

American Journal of Managed Care: SOCU News Coverage

By Media Coverage

hidradenitis suppurativa

American Journal of Managed Care wrote about a poster from Skin of Color Update 2024 that identified the populations most affected by hidradenitis suppurativa (HS). Researchers found those who are Black, female, a tobacco smoker, a public insurance holder, or disabled are more likely to have an HS diagnosis. The authors maintain that understanding the sociodemographics of HS allows dermatologists to better reach at-risk populations.

Register now for Skin of Color Update 2025 and increase your knowledge of hidradenitis suppurativa and other dermatologic conditions that disproportionately affect patients with skin of color.

Close Menu